{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:41:17Z","timestamp":1780321277021,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University Hospital Hamburg"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.psyneuen.2019.104433","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:52:13Z","timestamp":1567684333000},"page":"104433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms"],"prefix":"10.1016","volume":"110","author":[{"given":"Michael","family":"Kellner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.104433_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(00)00182-2","article-title":"Dose response of arginine vasopressin to the CCK-B agonist pentagastrin","volume":"24","author":"Abelson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4737082","article-title":"The circadian rhythm of copeptin, the C-terminal portion of arginine vasopressin","author":"Beglinger","year":"2017","journal-title":"J. Biomark."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098240","article-title":"Copeptin levels remain unchanged during menstrual cycle","volume":"9","author":"Blum","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin tetrapepide in panic disorder. Clinical and behavioural findings","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0025","first-page":"91","article-title":"Dose ranging study of the effects of cholecystokinin in healthy volunteers","volume":"16","author":"Bradwejn","year":"1991","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02244846","article-title":"Effects of flumazenile on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers","volume":"114","author":"Bradwejn","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0035","doi-asserted-by":"crossref","first-page":"E1750","DOI":"10.1210\/jc.2014-2244","article-title":"Sexual disparity of copeptin in healthy newborn infants","volume":"99","author":"Burckhardt","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1373\/clinchem.2009.141689","article-title":"Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment","volume":"56","author":"Darzy","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psyneuen.2016.11.006","article-title":"Copeptin \u2013 A potential endocrine surrogate marker of CCK-4-induced panic symptoms?","volume":"76","author":"Demiralay","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","article-title":"Measurement of lactate-induced panic and anxiety","volume":"20","author":"Dillon","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.11613\/BM.2013.021","article-title":"Copeptin and its potential role in diagnosis and prognosis of various diseases","volume":"23","author":"Dobsa","year":"2013","journal-title":"Biochem. Med."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0738-7","article-title":"Evalutation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"192","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0306-4530(00)00015-9","article-title":"Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects","volume":"25","author":"Flint","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12608","article-title":"Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress","volume":"82","author":"Kacheva","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0075","first-page":"341","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level","volume":"29","author":"Katan","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpsychires.2008.09.001","article-title":"The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype","volume":"43","author":"Kellner","year":"2009","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.31887\/DCNS.2011.13.4\/mkellner","article-title":"Experimental panic provocation in healthy man\u2014a translational role in anti-panic drug development?","volume":"13","author":"Kellner","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0090","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.brat.2005.10.012","article-title":"Sex differences in response to a panicogenic challenge procedure: an experimental evaluation of panic vulnerability in a non-clinical sample","volume":"44","author":"Kelly","year":"2006","journal-title":"Beh. Res. Ther."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0893-133X(98)00057-8","article-title":"Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases","volume":"20","author":"Le Mell\u00e9do","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0100","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0196-9781(01)00462-4","article-title":"Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide","volume":"22","author":"Le Mell\u00e9do","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000441-198804000-00017","article-title":"Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension","volume":"295","author":"Share","year":"1988","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.ajp.159.1.55","article-title":"Gender differences in panic disorder: findings from the national comorbidity survey","volume":"159","author":"Sheikh","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0006-3223(96)00334-4","article-title":"The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers","volume":"42","author":"Shlik","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0120","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1210\/jc.2011-1143","article-title":"Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects","volume":"96","author":"Simmler","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psyneuen.2015.10.009","article-title":"Association of HPA axis hormones with copeptin after psychological stress differs by sex","volume":"63","author":"Spanakis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0130","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1073\/pnas.0600406103","article-title":"Sex-specific influences of vasopressin on human social communication","volume":"103","author":"Thompson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.psychres.2010.04.003","article-title":"Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers","volume":"30","author":"T\u00f5ru","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.euroneuro.2012.08.011","article-title":"The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers","volume":"23","author":"T\u00f5ru","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104433_bib0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","article-title":"Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings","volume":"58","author":"Wiedemann","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.npp.1300131","article-title":"Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study","volume":"28","author":"Zwanzger","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/da.10099","article-title":"Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers","volume":"18","author":"Zwanzger","year":"2003","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2019.104433_bib0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S146114570600695X","article-title":"Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4)","volume":"10","author":"Zwanzger","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:06:51Z","timestamp":1759684011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019304184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"alternative-id":["S0306453019304184"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104433","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104433"}}